Hughes Robert N
Department of Psychology, University of Canterbury, Christchurch, New Zealand.
Behav Pharmacol. 2007 Nov;18(7):583-9. doi: 10.1097/FBP.0b013e3282eff0e8.
Despite abundant evidence of sex differences in the effects of drugs on nonsexual behaviour in rats and mice, most researchers continue to investigate male animals exclusively. This was evident from a survey of all relevant research reports published during the period February 2005-September 2006 (inclusive) in recent issues of five representative behavioural pharmacological journals. Reasons for excluding female animals from most studies are discussed along with attempts to justify the use of either male or female animals only, and the value of including both sexes (especially when a drug effect is poorly understood). Although there are other factors that can influence the effects of drugs, such as strain, age and social density, the sex of experimental animals is the easiest to control and thus is well suited to inclusion in pharmacological investigations. It is accordingly suggested that, as has been recommended many times in the past, animals' sex should play a more important part in future research than is still currently the case.
尽管有大量证据表明药物对大鼠和小鼠非性行为的影响存在性别差异,但大多数研究人员仍只对雄性动物进行研究。这一点从对2005年2月至2006年9月(含)期间在五种代表性行为药理学杂志近期期刊上发表的所有相关研究报告的调查中可以明显看出。文中讨论了在大多数研究中排除雌性动物的原因,以及仅使用雄性或雌性动物的理由,还有纳入两性的价值(特别是当对药物作用了解甚少时)。虽然还有其他因素会影响药物的作用,如品系、年龄和社会密度,但实验动物的性别是最容易控制的,因此非常适合纳入药理学研究。因此,建议正如过去多次所建议的那样,在未来的研究中,动物的性别应比目前发挥更重要的作用。